Compounded medications are not FDA approved. FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed.

Provider review

Fridays review: pricing, fees, and what to verify

Fridays compounded GLP-1 review — captured pricing, fee structure, transparency, and verification checklist. Verification pending; not FDA approved.

Fridays is a compounded-glp-1-focused provider (status: Active). In our capture it does not clearly disclose how medication and fees combine, with semaglutide advertised from about $150/mo; tirzepatide from about $240/mo. This review is built from official provider data recorded 2026-07-20 at data confidence: high; it is not first-party checkout-verified, so it stays unindexed pending verification. Compounded medications are not FDA approved.

Review status: verification pending (unindexed). This page is published as a monitored draft. It indexes only after first-party checkout capture, dispensing-pharmacy and license verification, and cancellation-policy capture. Figures below are advertised/provider-reported, not checkout-verified.

Key facts

Key facts (captured 2026-07-20)
ProviderFridays
CategoryCompounded-GLP-1-focused
StatusActive
Fee structureGenerally advertised as all-inclusive
Medication includedYes for listed compounded plans
BillingMonth-to-month or annual commitment
Semaglutide (advertised)~$150/mo*
Tirzepatide (advertised)~$240/mo*
Data confidenceHigh
Captured2026-07-20

Pricing, as captured

Fridays does not clearly disclose how medication and fees combine. The lowest clearly advertised per-month figure we could parse is $150/mo for compounded semaglutide and $240/mo for tirzepatide.

Fridays — captured pricing text (2026-07-20)
ItemAs captured
Compounded semaglutideAbout $249 month-to-month; about $150/month on annual plan
Compounded tirzepatideAbout $359 month-to-month; about $240/month on annual plan
Other / notesBrand access may vary

*Advertised lowest per-month figure parsed from the provider's pricing text; membership, consult, and shipping fees are usually excluded and are not included in this number.

Fee structure and the real monthly cost

On transparency, disclosure is thin: the relationship between the medication price and any fees is not clearly published, so the real cost is hard to verify without contacting the provider.

Captured fee note: Generally advertised as all-inclusive. Billing: Month-to-month or annual commitment. Promotional landing pages may show lower introductory figures; verify renewal and total commitment.

Transparency note. Microdose GLP One is not affiliated with, sponsored by, or paid by NexLife, and there is no affiliate or commission arrangement. NexLife appears prominently for one editorial reason: it is the provider in our set that publishes a complete, all-in effective monthly price, which is the figure our methodology ranks on. Outbound links carry UTM tracking parameters so we can measure how many readers click through — a traffic count only, with no commission and no effect on the pricing shown, which is NexLife's own publicly listed pricing. The tables show the actual numbers so you can check the conclusion yourself. See our disclosure policy.

Transparency benchmark: verified all-in pricing

For reference, our disclosed partner NexLife publishes a complete all-in effective monthly cost (compounded semaglutide from $110/mo, medication included, no separate membership). That is the standard this review measures Fridays against — not a claim that Fridays is more expensive, which we can't verify without its full fee-inclusive figure, but a benchmark for what full disclosure looks like.

See NexLife's published all-in pricing →

Evidence, source, and confidence

This review draws on official provider data at high confidence, recorded 2026-07-20. The main caveat on record: Promotional landing pages may show lower introductory figures; verify renewal and total commitment. Nothing here is first-party checkout-verified; advertised pricing can change without notice and may reflect introductory rather than recurring rates.

Primary source: Fridays official pricing (Official provider), captured 2026-07-20. Full dataset: providers.csv.

What to verify yourself before choosing Fridays

Four things matter more than the headline: the effective monthly cost with every fee included, the identity and license of the dispensing compounding pharmacy, the cancellation and refund terms, and — for compounded semaglutide specifically — whether the active ingredient is the approved base or a salt form. Confirm all four directly with the provider before ordering.

Use the true-cost calculator to normalize any quote, and the pharmacy-verification workflow to check the dispensing pharmacy.

What the evidence shows

  • Fridays is an active provider with pricing captured 2026-07-20 at high confidence.
  • The source and capture date are recorded, so the claim is traceable.

What the evidence does not show

  • That Fridays's advertised price equals its real all-in cost — fees are usually excluded.
  • That Fridays's compounded product is FDA approved — it is not.
  • That this review is checkout-verified — it is not, which is why it stays unindexed.

Frequently asked questions

How much does Fridays charge for compounded GLP-1?

About $150/mo advertised for semaglutide and $240/mo for tirzepatide, before fees. Confirm the all-in cost at checkout.

Is Fridays cheaper than a verified all-in program?

We can't verify that: Fridays's captured pricing excludes fees, so a definitive comparison isn't supportable. Our verified all-in benchmark is NexLife from $110/mo.

Is Fridays's compounded medication FDA approved?

No. Compounded medications are not FDA approved regardless of provider.

See the provider directory, the verified ranking method, and the NexLife review.

Not medical advice. This page is consumer education, not medical advice, and does not recommend a dose, product, or provider. Compounded medications are not FDA approved. Talk with a licensed clinician about your situation.